Projects

prof. Ing. Oľga Križanová, DrSc.
senior researcher

International

Finished
  • Biomarkers for Early Detection and Therapy of Adrenal Gland Tumors: Molecular Pathogenesis and Clinical Correlates
    Program: SRDA
    Duration: 1. 1. 2009 – 31. 12. 2014
  • Hypoxia sensing, signalling and adaptation
    Program: COST
    Duration: 16. 11. 2009 – 15. 11. 2013

National

Finished
  • Interactions of calcium transport systems in carcinogenesis
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Modulation of individual types of IP3 receptors in carcinogenesis and their impact on the effect of chemotherapeutics
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2024
  • Role of modulation of enzymes endogenously producing H2S in tumor cells
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2024
  • Strengthening of research, development and innovation capacities of translational biomedical research of human diseases
    Program:
    Duration: 1. 1. 2020 – 30. 6. 2023
  • Role of the hydrogen sulfide in remodelation cytoskeleton in colorectal carcinoma cells; impact on activity of taxanes
    Program: Other projects
    Duration: 1. 12. 2019 – 31. 12. 2022
  • Role of the calcium and calcium transport in tumorigenesis and tumor\'s treatment Key
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2021
  • Utilization of the calcium transport blockers as potential chemotherapeutics in a treatment of solid tumors
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Physiological relevance of medical and pharmaceutical sciences.
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2020
  • Multiple sclerosis - The role of mitochondrial dysfunction in insulin resistance.
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Study of biological effects of H2S/NO products and molecular mechanism of their actions
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 10. 2020
  • Sulfide signaling as a potential mechanism in tumor´s treatment
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Role of calcium signaing mediated by IP3 receptors in cancer cells derived from clear-cell carcinoma
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2018
  • Importance of the Na/Ca exchanger in ovarian tumor cells, its modulation and a role in inducing apoptosis.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2018
  • -
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2015
  • IP3 receptors, their modulation and function in cancer cells.
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Molecular mechanisms of the crosstalk between stress hormones and hypoxia in tumor cells: effect on expression and function of cancer-related protein CA IX
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
  • Centre of Excellence for Translational Research in Molecular medicine
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2010 – 31. 5. 2012
  • Center of Excelence for Translational Research in Molecular Medicine
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2009 – 31. 5. 2011
Employees